Cutaneous pseudolymphoma caused by tumor necrosis factor-α inhibitors was not induced by ustekinumab

被引：2
|
作者：
Imafuku, Shinichi [1 ]
Tatsukawa, Ryoko [1 ]
Ito, Kotaro [1 ]
Nakayama, Juichiro [1 ]
机构：
[1] Fukuoka Univ, Dept Dermatol, Fac Med, Fukuoka 8140180, Japan
来源：
JOURNAL OF DERMATOLOGY | 2012年 / 39卷 / 12期
关键词：
D O I：
10.1111/j.1346-8138.2012.01602.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1070 / 1070
页数：1
相关论文
共 50 条
  • [1] Cutaneous pseudolymphoma induced by tumor necrosis factor-alpha inhibitors
    Yokota, Masaki
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2022, 61 (06) : E217 - E219
  • [2] Cutaneous pseudolymphoma induced by tumor necrosis factor-alpha inhibitors (vol 61, pg e217, 2022)
    Yokota, Masaki
    Mitsuyama, Shinji
    Akimoto, Norihide
    Abe, Fumihito
    Hiruta, Nobuyuki
    Higuchi, Tetsuya
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (08) : 1102 - 1102
  • [3] Ustekinumab in the treatment of psoriasis in patients resistant to tumour necrosis factor-α inhibitors
    O'Shea, S. J.
    Rogers, S.
    Kirby, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2010, 163 (02) : 444 - 444
  • [4] A Case of Tumor Necrosis Factor-α Inhibitors-induced Pustular Psoriasis
    Park, Jae-Jeong
    Lee, Seung-Chul
    ANNALS OF DERMATOLOGY, 2010, 22 (02) : 212 - 215
  • [5] Vasculitis Associated With Tumor Necrosis Factor-α Inhibitors
    Sokumbi, Olayemi
    Wetter, David A.
    Makol, Ashima
    Warrington, Kenneth J.
    MAYO CLINIC PROCEEDINGS, 2012, 87 (08) : 739 - 745
  • [6] The Risk of Infections With Tumor Necrosis Factor-α Inhibitors
    Jassal, Mandeep S.
    Bishai, William R.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2009, 15 (08) : 419 - 426
  • [7] Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors
    Bang, Chul Hwan
    Oh, Hyun Ju
    Kim, Yeong Ho
    Jung, Jin-Hyung
    Lee, Ji Hyun
    Park, Young Min
    Han, Ju Hee
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [8] Pustulosis of the folds induced by tumor necrosis factor-α inhibitors: a new dermatologic entity?
    Raimbault, C.
    Topin, S.
    Bourneau-Martin, D.
    Lagarce, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 50 - 50
  • [9] Tumor necrosis factor-α inhibitors and congestive heart failure
    Behnam, S
    Koo, JY
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P201 - P201
  • [10] Response of Pediatric Uveitis to Tumor Necrosis Factor-α Inhibitors
    Lerman, Melissa A.
    Burnham, Jon M.
    Chang, Peter Y.
    Daniel, Ebenezer
    Foster, C. Stephen
    Hennessy, Sean
    Jabs, Douglas A.
    Joffe, Marshall M.
    Kacmaz, R. Oktay
    Levy-Clarke, Grace A.
    Mills, Monte D.
    Nussenblatt, Robert B.
    Rosenbaum, James T.
    Suhler, Eric B.
    Thorne, Jennifer E.
    Kempen, John H.
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (08) : 1394 - 1403
12345